Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Penn-Nicholson

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Scientific Reports|May 27, 2020
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment responseAdam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, et al.
The Lancet. Respiratory Medicine|December 11, 2020
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trialTracey A Day, Adam Penn-Nicholson, Angelique Kany Kany Luabeya, et al.
The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.
Nature Communications|April 13, 2016
T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
Nature Communications|May 7, 2016
Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2021
Longitudinal Dynamics of a Blood Transcriptomic Signature of TuberculosisHumphrey Mulenga, Munyaradzi Musvosvi, Simon C Mendelsohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2025
Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy StudyJayne S Sutherland, Gian D van der Spuy, Jane A Shaw, et al.
BMC Infectious Diseases|July 3, 2023
Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB)Tracy R Richardson, Bronwyn Smith, Stephanus T Malherbe, et al.
Lancet (London, England)|March 28, 2016
A blood RNA signature for tuberculosis disease risk: a prospective cohort studyDaniel E Zak, Adam Penn-Nicholson, Thomas J Scriba, et al.
Open Forum Infectious Diseases|April 23, 2025
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND CohortNisreen Khambati, Kanyange Angel Moureen, Francesca Wanda Basile, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Scientific Reports|May 27, 2020
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment responseAdam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, et al.
The Lancet. Respiratory Medicine|December 11, 2020
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trialTracey A Day, Adam Penn-Nicholson, Angelique Kany Kany Luabeya, et al.
The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.
Nature Communications|April 13, 2016
T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
Nature Communications|May 7, 2016
Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2021
Longitudinal Dynamics of a Blood Transcriptomic Signature of TuberculosisHumphrey Mulenga, Munyaradzi Musvosvi, Simon C Mendelsohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2025
Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy StudyJayne S Sutherland, Gian D van der Spuy, Jane A Shaw, et al.
BMC Infectious Diseases|July 3, 2023
Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB)Tracy R Richardson, Bronwyn Smith, Stephanus T Malherbe, et al.
Lancet (London, England)|March 28, 2016
A blood RNA signature for tuberculosis disease risk: a prospective cohort studyDaniel E Zak, Adam Penn-Nicholson, Thomas J Scriba, et al.
Open Forum Infectious Diseases|April 23, 2025
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND CohortNisreen Khambati, Kanyange Angel Moureen, Francesca Wanda Basile, et al.
Pageof 10